Association of plasma biomarkers, p-tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long-term clinical Alzheimer's disease risk: results from a prospective cohort followed over 17 years

Blood biomarkers for Alzheimer's disease (AD) are the future of AD risk assessment. The aim of this study was to determine the association between plasma-measured phosphorylated tau (p-tau181), glial fibrillary acidic protein (GFAP), and neurofilament light (NfL) levels and risk of clinical AD...

Full description

Bibliographic Details

Main Authors:	Stocker, Hannah (Author) , Beyer, Léon (Author) , Perna, Laura (Author) , Rujescu, Dan (Author) , Holleczek, Bernd (Author) , Beyreuther, Konrad (Author) , Stockmann, Julia (Author) , Schöttker, Ben (Author) , Gerwert, Klaus (Author) , Brenner, Hermann (Author)
Format:	Article (Journal)
Language:	English
Published:	14 January 2023
In:	Alzheimer's and dementia Year: 2023, Volume: 19, Pages: 25-35
ISSN:	1552-5279
DOI:	10.1002/alz.12614
Online Access:	Resolving-System, kostenfrei, Volltext: https://doi.org/10.1002/alz.12614 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/alz.12614
Author Notes:	Hannah Stocker, Léon Beyer, Laura Perna, Dan Rujescu, Bernd Holleczek, Konrad Beyreuther, Julia Stockmann, Ben Schöttker, Klaus Gerwert, Hermann Brenner